Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of HCA Healthcare Inc (NYSE: HCA) closed at $473.2 in the last session, up 0.32% from day before closing price of $471.68. In other words, the price has increased by $0.32 from its previous closing price. On the day, 1.1 million shares were traded. HCA stock price reached its highest trading level at $477.75 during the session, while it also had its lowest trading level at $465.77.
Ratios:
We take a closer look at HCA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 98.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.34. For the most recent quarter (mrq), Quick Ratio is recorded 0.76 and its Current Ratio is at 0.85.
BofA Securities Downgraded its Buy to Neutral on July 16, 2025, while the target price for the stock was maintained at $394.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 05 ’25 when McAlevey Michael R sold 3,892 shares for $473.79 per share. The transaction valued at 1,843,991 led to the insider holds 3,487 shares of the business.
Michael R McAlevey bought 3,892 shares of HCA for $1,843,991 on Nov 05 ’25. On Sep 08 ’25, another insider, Cuffe Michael S., who serves as the Officer of the company, bought 3,836 shares for $418.84 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCA now has a Market Capitalization of 107981357056 and an Enterprise Value of 156415361024. As of this moment, HCA’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.29, and their Forward P/E ratio for the next fiscal year is 15.91. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.25. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.45. Its current Enterprise Value per Revenue stands at 2.103 whereas that against EBITDA is 10.358.
Stock Price History:
The Beta on a monthly basis for HCA is 1.37, which has changed by 0.3248322 over the last 52 weeks, in comparison to a change of 0.13367426 over the same period for the S&P500. Over the past 52 weeks, HCA has reached a high of $478.19, while it has fallen to a 52-week low of $289.98. The 50-Day Moving Average of the stock is 11.32%, while the 200-Day Moving Average is calculated to be 27.53%.
Shares Statistics:
According to the various share statistics, HCA traded on average about 1.28M shares per day over the past 3-months and 1693190 shares per day over the past 10 days. A total of 229.85M shares are outstanding, with a floating share count of 162.19M. Insiders hold about 28.92% of the company’s shares, while institutions hold 66.33% stake in the company. Shares short for HCA as of 1760486400 were 3263233 with a Short Ratio of 2.56, compared to 1757894400 on 4228281. Therefore, it implies a Short% of Shares Outstanding of 3263233 and a Short% of Float of 2.0499999.
Dividends & Splits
The forward annual dividend rate for HCA is 2.82, which was 2.82 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.0059786295. The stock’s 5-year Average Dividend Yield is 0.75.
Earnings Estimates
The stock of HCA Healthcare Inc (HCA) is currently in the spotlight, with 19.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $7.19, with high estimates of $7.6 and low estimates of $6.78.
Analysts are recommending an EPS of between $28.22 and $26.56 for the fiscal current year, implying an average EPS of $27.65. EPS for the following year is $29.69, with 22.0 analysts recommending between $31.42 and $26.35.
Revenue Estimates
According to 19 analysts,. The current quarter’s revenue is expected to be $19.65B. It ranges from a high estimate of $20.05B to a low estimate of $19.2B. As of. The current estimate, HCA Healthcare Inc’s year-ago sales were $18.29BFor the next quarter, 19 analysts are estimating revenue of $19.18B. There is a high estimate of $19.42B for the next quarter, whereas the lowest estimate is $18.61B.
A total of 22 analysts have provided revenue estimates for HCA’s current fiscal year. The highest revenue estimate was $76.14B, while the lowest revenue estimate was $74.48B, resulting in an average revenue estimate of $75.64B. In the same quarter a year ago, actual revenue was $70.6BBased on 21 analysts’ estimates, the company’s revenue will be $79.06B in the next fiscal year. The high estimate is $80.6B and the low estimate is $77B.
